Curious to see your top suppliers emissions?
Book a demo for a pilot project
Book a demo for a pilot project
Roche Diagnostics Corporation, a subsidiary of the Swiss multinational Roche Holding AG, is a leading player in the global healthcare industry, headquartered in the United States. Established in 1896, Roche has consistently innovated in diagnostics, focusing on areas such as molecular diagnostics, tissue diagnostics, and point-of-care testing.
With a strong presence in North America, Europe, and Asia, Roche Diagnostics is renowned for its cutting-edge products, including the cobas® series of diagnostic systems and the Elecsys® immunoassay platform. These offerings are distinguished by their accuracy, speed, and ability to deliver comprehensive results, making them invaluable in clinical settings.
Roche Diagnostics holds a prominent market position, recognised for its commitment to advancing personalised healthcare and achieving significant milestones in diagnostic technology.
+48 vs industry average
Roche Diagnostics Corporation’s score of 88 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Roche Diagnostics Corporation yet.
Roche Diagnostics Corporation, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. As a current subsidiary of Roche Holding AG, any climate commitments or emissions data would be inherited from its parent company.
Roche Holding AG has made significant strides in addressing climate change, including setting science-based targets for emissions reductions. However, specific reduction targets or achievements for Roche Diagnostics Corporation are not detailed in the available information.
The company is committed to sustainability and actively participates in initiatives such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are cascaded from Roche Holding AG. These initiatives reflect a broader commitment to reducing carbon emissions across its operations, although specific metrics for Roche Diagnostics Corporation are not provided.
In summary, while Roche Diagnostics Corporation's individual emissions data is currently unavailable, it aligns with the climate commitments and reduction initiatives of its parent company, Roche Holding AG, demonstrating a commitment to sustainability and climate action within the diagnostics industry.
Access structured emission data, company specific factors and auditable source documents
No climate goals have been disclosed for Roche Diagnostics Corporation yet.
No scope 3 category breakdown has been disclosed yet.


No peer comparison is available for Roche Diagnostics Corporation yet.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more